Parathyropar Liquid
NDC Package 44911-0902-1
Package Information
Parathyropar (symphytum officinale, baryta carbonica, calcarea carbonica, calcarea phosphorica, hekla lava, manganum metallicum, parathyroid gland (bovine), rhus tox, silicea) liquids is adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0902.
Identification & Billing
Clinical Specifications
- BARIUM CARBONATE 12 [hp_X]/mL
- BOS TAURUS PARATHYROID GLAND 12 [hp_X]/mL
- COMFREY ROOT 6 [hp_X]/mL
- HEKLA LAVA 12 [hp_X]/mL
- MANGANESE 12 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X]/mL
- SILICON DIOXIDE 12 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF 12 [hp_X]/mL
- TRIBASIC CALCIUM PHOSPHATE 12 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0902 - Parathyropar
- 44911-0902-1 - 30 mL in 1 BOTTLE, DROPPER
- 44911-0902 - Parathyropar
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0902-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Parathyropar, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains barium carbonate; bos taurus parathyroid gland; comfrey root; hekla lava; manganese; oyster shell calcium carbonate, crude; silicon dioxide; toxicodendron pubescens leaf; tribasic calcium phosphate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on January 05, 2026. The current certification is valid through December 31, 2027.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911090201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.